These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

753 related articles for article (PubMed ID: 19708783)

  • 21. Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot study.
    Oto A; Fan X; Mustafi D; Jansen SA; Karczmar GS; Rubin DT; Kayhan A
    Acad Radiol; 2009 Oct; 16(10):1223-30. PubMed ID: 19524458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic contrast-enhanced-MRI of tumor hypoxia.
    Egeland TA; Gulliksrud K; Gaustad JV; Mathiesen B; Rofstad EK
    Magn Reson Med; 2012 Feb; 67(2):519-30. PubMed ID: 21661044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic contrast-enhanced magnetic resonance imaging for pancreatic ductal adenocarcinoma at 3.0-T magnetic resonance: correlation with histopathology.
    Liu K; Xie P; Peng W; Zhou Z
    J Comput Assist Tomogr; 2015; 39(1):13-8. PubMed ID: 25340589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of pancreatic cancer by multiple breath-hold dynamic contrast-enhanced magnetic resonance imaging at 3.0T.
    Yao X; Zeng M; Wang H; Sun F; Rao S; Ji Y
    Eur J Radiol; 2012 Aug; 81(8):e917-22. PubMed ID: 22695786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluctuations in tumor blood perfusion assessed by dynamic contrast-enhanced MRI.
    Brurberg KG; Benjaminsen IC; Dørum LM; Rofstad EK
    Magn Reson Med; 2007 Sep; 58(3):473-81. PubMed ID: 17763357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical evaluation of Gd-DTPA and gadomelitol as contrast agents in DCE-MRI of cervical carcinoma interstitial fluid pressure.
    Hompland T; Ellingsen C; Rofstad EK
    BMC Cancer; 2012 Nov; 12():544. PubMed ID: 23173554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of liver function in thioacetamide-induced rat acute liver injury using an empirical mathematical model and dynamic contrast-enhanced MRI with Gd-EOB-DTPA.
    Saito S; Moriyama Y; Kobayashi S; Ogihara R; Koto D; Kitamura A; Matsushita T; Nishiura M; Murase K
    J Magn Reson Imaging; 2012 Dec; 36(6):1483-9. PubMed ID: 22711439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A general dual-bolus approach for quantitative DCE-MRI.
    Kershaw LE; Cheng HL
    Magn Reson Imaging; 2011 Feb; 29(2):160-6. PubMed ID: 21129878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of quantitative and semiquantitative dynamic contrast-enhanced MRI with respect to their correlation to delayed gadolinium-enhanced MRI of the cartilage in patients with early rheumatoid arthritis.
    Müller-Lutz A; Schleich C; Sewerin P; Gross J; Pentang G; Wittsack HJ; Antoch G; Schneider M; Ostendorf B; Miese F
    J Comput Assist Tomogr; 2015; 39(1):64-9. PubMed ID: 25340588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computer-aided diagnosis of breast DCE-MRI using pharmacokinetic model and 3-D morphology analysis.
    Wang TC; Huang YH; Huang CS; Chen JH; Huang GY; Chang YC; Chang RF
    Magn Reson Imaging; 2014 Apr; 32(3):197-205. PubMed ID: 24439361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing liver function using dynamic Gd-EOB-DTPA-enhanced MRI with a standard 5-phase imaging protocol.
    Saito K; Ledsam J; Sourbron S; Otaka J; Araki Y; Akata S; Tokuuye K
    J Magn Reson Imaging; 2013 May; 37(5):1109-14. PubMed ID: 23086736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DCE-MRI using small-molecular and albumin-binding contrast agents in experimental carcinomas with different stromal content.
    Farace P; Merigo F; Fiorini S; Nicolato E; Tambalo S; Daducci A; Degrassi A; Sbarbati A; Rubello D; Marzola P
    Eur J Radiol; 2011 Apr; 78(1):52-9. PubMed ID: 19443159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic contrast-enhanced magnetic resonance imaging of tumor interstitial fluid pressure.
    Gulliksrud K; Brurberg KG; Rofstad EK
    Radiother Oncol; 2009 Apr; 91(1):107-13. PubMed ID: 18973959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.
    Kim JH; Lee JM; Park JH; Kim SC; Joo I; Han JK; Choi BI
    Radiology; 2013 Jan; 266(1):185-96. PubMed ID: 23192779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic contrast enhanced MRI of the prostate: comparison of gadobutrol and Gd-DTPA.
    Durmus T; Vollnberg B; Schwenke C; Kilic E; Huppertz A; Taupitz M; Franiel T
    Rofo; 2013 Sep; 185(9):862-8. PubMed ID: 23888476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model.
    Yankeelov TE; Luci JJ; Lepage M; Li R; Debusk L; Lin PC; Price RR; Gore JC
    Magn Reson Imaging; 2005 May; 23(4):519-29. PubMed ID: 15919597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of microvascular density, extracellular volume fraction, and radiobiological hypoxia in human melanoma xenografts by dynamic contrast-enhanced MRI.
    Vestvik IK; Egeland TA; Gaustad JV; Mathiesen B; Rofstad EK
    J Magn Reson Imaging; 2007 Oct; 26(4):1033-42. PubMed ID: 17896373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of model-based arterial input functions for dynamic contrast-enhanced MRI in tumor bearing rats.
    McGrath DM; Bradley DP; Tessier JL; Lacey T; Taylor CJ; Parker GJ
    Magn Reson Med; 2009 May; 61(5):1173-84. PubMed ID: 19253360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization.
    Kim JK; Hong SS; Choi YJ; Park SH; Ahn H; Kim CS; Cho KS
    J Magn Reson Imaging; 2005 Nov; 22(5):639-46. PubMed ID: 16200542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.